Acute toxicity evaluation of a novel ceramide analog for the treatment of breast cancer

We have previously reported that treating triple-negative tumor bearing nude mice with intraperitoneal (ip) 10 mg/kg body weight of (S,E)-3-hydroxy-2-(2-hydroxybenzylidene)amino-N-tetradecylpropanamide, a ceramide analog, 5 days per week for 3 weeks, was shown not only to suppress tumor growth but a...

Description complète

Détails bibliographiques

Auteurs principaux:	Tulasi Ponnapakkam, Kyla Bongay-Williams, Teresa Beamon, Royce Hooks, Degrick Cheatham, Navneet Goyal, Muralidharan Anbalagan, Maryam Foroozesh
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2021-01-01
Collection:	Toxicology Reports
Sujets:	Ceramide Toxicology Drug Breast cancer Biochemical parameters
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2214750021001499
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!